Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RMND5A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | FAM86C1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | DPY19L4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | NME2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | PTBP2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | GXYLT2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | TP53I11 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | GOLGA8O | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | CTD-2561J22.3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | TCF7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |